Registered entities
Innovation
49 patent families (17 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace accelerating. Cited 2,000 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 11 |
| 2023 | 32 |
| 2024 | 33 |
| 2025 | 26 |
| 2026 | 17 |
Social engagement
Social engagement: 30.3K social following, 5 posts in the last 12 months — below the industry typical range.
Investor mix
19 investors on record; lead investors include Perceptive Advisors; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 37% |
| Private equity | 4 | 21% |
| Bank & private debt | 1 | 5% |
| Other / undisclosed | 7 | 37% |
Hiring activity
Hires occasionally
2 roles tracked across 1 of the last 12 months
13 Nov 2025 · Senior Director, US NF1-PN Regional Marketing · Stamford
7 Nov 2025 · Senior Medical Science Liaison - South Central Region · Dallas
31 Oct 2025 · Medical Science Liaison Rare Tumors Switzerland (all genders) · Zug
3 Oct 2025 · Senior Director, Brand Lead, US Marketing · Boston
19 Sep 2025 · Director, US Marketing · Boston
Based on job postings tracked across public sources.